Impacts of transient exposure of human T cells to low oxygen, temperature, pH and nutrient levels relevant to bioprocessing for cell therapy applications
Overall, when developing processes and devices for T-cell therapy manufacturing that involve concentrated cells, the results of this study indicate that more practically feasible room temperatures can be used for up to 3 h to obtain high viable cell recoveries whereas lower temperatures such as 4°C should be used if there is a need for more prolonged concentrated T-cell conditions.
Authors
- Alina Kunitskaya (ORCID: https://orcid.org/0009-0006-1686-3603)
- James M. Piret (ORCID: https://orcid.org/0000-0001-7934-9675)
Institutions
- University of British Columbia (CA)
- Canada's Michael Smith Genome Sciences Centre (CA)
Publication Details
- Journal
- Cytotherapy
- Published
- 2025-01-09
- DOI
- https://doi.org/10.1016/j.jcyt.2025.01.002
- Citations
- 1
- Primary Topic
- CAR-T cell therapy research
- Type
- article
- Field-Weighted Citation Impact
- 1.05
Funders
- Canadian Institutes of Health Research
- Natural Sciences and Engineering Research Council of Canada